Imexpharm Corporation (HOSE:IMP)
Vietnam
· Delayed Price · Currency is VND 53,900
-400 (-0.74%)
At close: Mar 6, 2026
Imexpharm Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 8,270,281 | 8,085,471 | 7,238,421 | 3,962,167 | 4,013,628 | 5,187,048 | Upgrade
|
| Market Cap Growth | 9.93% | 11.70% | 82.69% | -1.28% | -22.62% | 38.19% | Upgrade
|
| Enterprise Value | 8,081,765 | 8,062,671 | 7,072,195 | 3,840,834 | 3,828,514 | 5,172,206 | Upgrade
|
| Last Close Price | 53700.00 | 52500.00 | 46549.81 | 25168.19 | 25127.46 | 31748.83 | Upgrade
|
| PE Ratio | 27.17 | 26.56 | 24.33 | 14.26 | 21.83 | 29.89 | Upgrade
|
| Forward PE | 22.53 | 19.33 | 19.33 | 19.33 | 19.33 | 19.33 | Upgrade
|
| PS Ratio | 3.39 | 3.31 | 3.28 | 1.99 | 2.44 | 4.10 | Upgrade
|
| PB Ratio | 3.59 | 3.51 | 3.32 | 1.90 | 2.12 | 2.89 | Upgrade
|
| P/TBV Ratio | 3.70 | 3.62 | 3.43 | 1.97 | 2.20 | 3.01 | Upgrade
|
| P/FCF Ratio | 303.03 | 296.26 | 60.57 | - | 14.37 | 28.50 | Upgrade
|
| P/OCF Ratio | 152.67 | 149.26 | 33.47 | - | 10.60 | 22.08 | Upgrade
|
| EV/Sales Ratio | 3.31 | 3.30 | 3.21 | 1.93 | 2.33 | 4.08 | Upgrade
|
| EV/EBITDA Ratio | 14.29 | 14.26 | 13.62 | 8.28 | 10.73 | 17.56 | Upgrade
|
| EV/EBIT Ratio | 17.48 | 17.43 | 17.04 | 10.08 | 12.91 | 22.10 | Upgrade
|
| EV/FCF Ratio | 296.12 | 295.42 | 59.18 | - | 13.71 | 28.42 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.04 | 0.02 | 0.05 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.38 | 0.38 | 0.17 | 0.11 | 0.27 | 0.90 | Upgrade
|
| Debt / FCF Ratio | 7.80 | 7.80 | 0.72 | - | 0.34 | 1.45 | Upgrade
|
| Net Debt / Equity Ratio | -0.08 | -0.08 | -0.10 | -0.07 | -0.16 | -0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.33 | -0.33 | -0.42 | -0.32 | -0.83 | -0.41 | Upgrade
|
| Net Debt / FCF Ratio | -6.91 | -6.91 | -1.82 | 1.45 | -1.06 | -0.66 | Upgrade
|
| Asset Turnover | 0.92 | 0.92 | 0.90 | 0.85 | 0.72 | 0.58 | Upgrade
|
| Inventory Turnover | 1.85 | 1.85 | 1.68 | 1.78 | 1.78 | 1.46 | Upgrade
|
| Quick Ratio | 2.05 | 2.05 | 2.00 | 1.49 | 1.62 | 1.56 | Upgrade
|
| Current Ratio | 4.05 | 4.05 | 4.38 | 3.92 | 2.89 | 2.88 | Upgrade
|
| Return on Equity (ROE) | 15.55% | 15.55% | 15.04% | 15.06% | 12.12% | 10.73% | Upgrade
|
| Return on Assets (ROA) | 10.93% | 10.93% | 10.60% | 10.20% | 8.11% | 6.66% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.85% | 17.72% | 16.90% | 17.12% | 13.89% | 10.94% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.20% | 19.20% | 19.00% | 18.30% | 15.70% | 12.40% | Upgrade
|
| Earnings Yield | 3.68% | 4.32% | 4.43% | 7.56% | 5.57% | 3.65% | Upgrade
|
| FCF Yield | 0.33% | 0.34% | 1.65% | -2.60% | 6.96% | 3.51% | Upgrade
|
| Dividend Yield | 0.93% | - | 1.07% | 1.81% | 1.72% | 2.04% | Upgrade
|
| Payout Ratio | 22.06% | 22.05% | 21.82% | 22.26% | 44.74% | 52.89% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | 0.00% | 0.00% | -2.92% | Upgrade
|
| Total Shareholder Return | 0.93% | - | 1.07% | 1.81% | 1.72% | -0.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.